Title: First Division T32 Fellow Receives K Award
We are pleased to announce Dr. Jessica Magidson, the first fellow in the MGH Global Psychiatric Clinical Research Training Program (T32), is also our first fellow to receive a K award from NIH. She has been awarded a K23 award from the National Institute on Drug Abuse (NIDA) entitled, "Hybrid Effectiveness-Implementation Trial for ART Adherence and Substance Use in HIV Care in South Africa." It is a 5-year research grant to develop and evaluate a lay counselor-delivered intervention for substance use and HIV medication adherence in primary HIV care in Cape Town, South Africa.
During her 3-year fellowship, Dr. Magidson has collaborated with numerous T32 faculty, including Drs. Steve Safren, David Bangsberg and Conall O’Cleirigh at MGH, and John Joska and Ashraf Kagee in South Africa. She will continue to work closely with them on this project and will also receive advanced training in implementation science.
Dr. Magidson has co-authored over 50 peer-reviewed articles and book chapters and has presented her research at numerous conferences. She received her Ph.D. in clinical psychology from the University of Maryland and completed her pre-doctoral clinical internship at MGH in Behavioral Medicine. She received her undergraduate degree Phi Beta Kappa and summa cum laude from Dartmouth College in 2006.
In addition to research, she also conducts clinical work in the Behavioral Medicine Service at MGH using cognitive behavioral therapy and mindfulness-based approaches for depression and anxiety. Dr. Magidson formerly taught the University of Maryland Education Abroad course in South Africa, which focused on the HIV/AIDS epidemic and the history of apartheid.
BACK TO EVENTS/NEWS PAGE